Medico Remedies Reports Strong Financial Growth and Improved Operational Efficiency in May 2025 Results

Medico Remedies, a microcap player in the Pharmaceuticals & Drugs industry, has recently reported its financial results for the quarter ending March 2025. The results, declared on May 8, 2025, indicate a notable shift in the company's financial standing, as reflected in an adjustment in its evaluation score, which has risen significantly over the past three months.
The financial data reveals that Medico Remedies achieved a Profit Before Tax less Other Income (PBT) of Rs 5.41 crore, marking a year-on-year growth of 47.41%. This positive trend is mirrored in the Profit After Tax (PAT), which reached Rs 4.34 crore, reflecting a year-on-year increase of 40.0%. Additionally, the company reported its highest Operating Profit (PBDIT) in the last five quarters at Rs 6.67 crore, alongside an Operating Profit Margin of 16.15%, indicating improved operational efficiency.

Furthermore, the Earnings per Share (EPS) also reached its peak at Rs 0.52 in the last five quarters, showcasing the company's ability to generate higher earnings for its shareholders. Overall, the financial results suggest a robust performance for Medico Remedies in the recent quarter.

Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.